Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page
- ChecktodayChange DetectedPage revision updated from v3.6.0 to v3.6.3, indicating a newer version of the page template or rendering. This change is a metadata/version update and does not modify the study’s content or user-facing details.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedNew help/navigation sections were added to the page—How to Read a Study Record, Common Questions, How to Join a Study—and the Intervention/Treatment header appears, replacing the previous Intervention / Treatment heading. The page revision tag was updated to v3.6.0 (from v3.5.5).SummaryDifference0.5%

- Check22 days agoChange DetectedRevision: v3.5.5 was applied, updating the page from v3.5.4. This is a minor revision that does not change the study details or other substantive content on the page.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4. This indicates a minor metadata version upgrade for the page.SummaryDifference0.1%

- Check65 days agoChange DetectedUpdated the website revision indicator in the page footer from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision tag was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.